Frazier Life Sciences Management, L.P. Aura Biosciences, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.9 Billion
- Q2 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 5,100,000 shares of AURA stock, worth $35.4 Million. This represents 1.68% of its overall portfolio holdings.
Number of Shares
5,100,000Holding current value
$35.4 Million% of portfolio
1.68%Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
98Shares Held
41MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$48 Million22.54% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$33.9 Million0.05% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$30.3 Million0.94% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.32MShares$23 Million0.67% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$21.1 Million5.39% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $203M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...